Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhipeng Zeng

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Frontiers in Oncology|October 25, 2021
Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal AdenocarcinomaYixi Li, Dehua Li, Yang Chen, et al.
Journal of Proteomics|April 30, 2022
Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomicsJingjing Dong, Jingquan He, Zeyu Zhang, et al.
Annals of the Rheumatic Diseases|July 18, 2025
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritisZiwei Hu, Shaozhe Cai, Yikai Yu, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Frontiers in Oncology|October 25, 2021
Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal AdenocarcinomaYixi Li, Dehua Li, Yang Chen, et al.
Journal of Proteomics|April 30, 2022
Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomicsJingjing Dong, Jingquan He, Zeyu Zhang, et al.
Annals of the Rheumatic Diseases|July 18, 2025
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritisZiwei Hu, Shaozhe Cai, Yikai Yu, et al.
Pageof 9